Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma
Alessio Giubellino(University of Minnesota), Karel Pacák(Unknown)
Cited by 26
Related Papers
The Role of [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography and [<sup>111</sup>In]-Diethylenetriaminepentaacetate-<scp>d</scp>-Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing’s Syndrome
|The Journal of Clinical Endocrinology & Metabolism|2004|138
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [123I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites
|Nuclear Medicine Communications|2005|91
Combined Inhibition of mTORC1 and mTORC2 Signaling Pathways Is a Promising Therapeutic Option in Inhibiting Pheochromocytoma Tumor Growth: In Vitro and In Vivo Studies in Female Athymic Nude Mice
|Endocrinology|2013|45
Inhibitory Effect of the Noncamptothecin Topoisomerase I Inhibitor LMP-400 on Female Mice Models and Human Pheochromocytoma Cells
|Endocrinology|2015|13
Clinical Review: The Approach to the Evaluation and Management of Bilateral Adrenal Masses
|Endocrine Practice|2024|11